Key result
Alpha-1-adrenergic blockers reduce blood pressure by decreasing peripheral resistance and improve plasma lipoprotein profiles, whereas beta-blockers tend to adversely affect lipid profiles.
Why the study?
Do alpha 1-adrenergic blockers improve blood pressure and lipid profiles compared to beta-blockers in essential hypertension?
Do alpha 1-adrenergic blockers improve blood pressure and lipid profiles compared to beta-blockers in essential hypertension?
Alpha 1-adrenergic blockers offer a dual benefit in hypertension management by effectively lowering blood pressure and improving lipid profiles, unlike beta-blockers which may worsen lipid parameters.
Answers are grounded in this paper and cite their sources.
Alpha-1 blockers offer rational hypertension therapy; leaves open their role versus modern agents in guidelines.
The sympathetic nervous system plays a major role in the pathogenesis of essential hypertension and is mediated by the alpha and beta receptors. The alpha receptor is divided into two types, alpha 1 and alpha 2, based on response to epinephrine and norepinephrine. alpha 1-Adrenergic receptors have a high affinity for drugs such as prazosin, doxazosin, and terazosin, which act to reduce blood pressure by selective blockade of the receptor. These agents provide a rational approach to the treatment of hypertension by correcting elevated total peripheral resistance, the fundamental hemodynamic abnormality in essential hypertension. In contrast, early alpha-adrenergic receptor blockers nonselectively blocked both alpha 1 and alpha 2 receptors and were unsuitable as antihypertensive agents because they induced tachycardia and patients developed a tolerance to them rapidly. alpha 1-Adrenergic blockers also have beneficial effects on plasma lipoproteins, tending to decrease levels of triglycerides and cholesterol and increase levels of high-density lipoprotein (HDL) cholesterol and the HDL cholesterol/total cholesterol ratio. beta-Adrenergic blockers, such as propranolol and atenolol, have been shown to have an adverse effect on the lipid profile by tending to increase levels of triglycerides and decrease HDL cholesterol. A number of mechanisms contribute to these effects, in particular, adrenergic modulation of lipoprotein lipase and the triglyceride secretion rate. Doxazosin has been shown to increase the activity of LDL receptors, which may be partly responsible for its beneficial effect on plasma lipids and lipoproteins.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
David T. Nash (1990) conducted a review in Essential hypertension. Alpha-1-adrenergic blockers vs. Beta-adrenergic blockers was evaluated. Alpha-1-adrenergic blockers reduce blood pressure by decreasing peripheral resistance and improve plasma lipoprotein profiles, whereas beta-blockers tend to adversely affect lipid profiles.
Synapse has enriched 10 related papers. Consider them for comparative context: